Divergent effects of taurolidine as potential anti-neoplastic agent: Inhibition of bladder carcinoma cells in vitro and promotion of bladder tumor in vivo

Claudia Abramjuk, Michael Bueschges, Jörg Schnorr, Klaus Jung, Andrea Staack, Michael Lein

Research output: Contribution to journalArticlepeer-review

Abstract

We investigated taurolidine (TRD) against various human bladder cell lines and the AY-27 rat bladder carcinoma cells. In vitro we tested the effect of TRD in ascending concentrations depending on different incubation times on cell proliferation by the XTT-test. Taurolidine had an inhibitory effect on all tested cell lines. Increasing concentrations and longer incubation times decreased the proliferation depending on the primary quantities of cells. For in vivo studies, an orthotopic rat bladder carcinoma was used. The animals were treated intravenously or intravesically and the tumors were harvested and weighted after the study. In contrast to other authors we could not find any anti-proliferative effect, we actually showed that instillation into the rat urinary bladder enhanced tumor growth.

Original languageEnglish
Pages (from-to)409-414
Number of pages6
JournalOncology Reports
Volume22
Issue number2
DOIs
StatePublished - 2009

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

Keywords

  • Anti-neoplastic agent
  • Bladder cancer
  • Rat tumor model
  • Taurolidine
  • Tumor growth

Cite this